Tonix Pharmaceuticals Holding Corp. Stock
Our community identified positive and negative aspects for Tonix Pharmaceuticals Holding Corp. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Tonix Pharmaceuticals Holding Corp. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Tonix Pharmaceuticals Holding Corp. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Tonix Pharmaceuticals Holding Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -5.660% | -35.714% | -23.680% | -74.673% | -74.309% | -81.771% | -97.186% |
| Evolus Inc | -0.740% | 23.433% | 12.001% | 29.160% | 18.495% | -25.770% | -32.021% |
| Rhythm Pharmaceuticals | -1.010% | 10.615% | 4.211% | 28.571% | 5.882% | 341.964% | 768.421% |
Comments
Tonix Pharmaceuticals (TNXP) had its "strong-buy" rating reaffirmed by Raymond James Financial, Inc..
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals (TNXP) was upgraded by Raymond James Financial, Inc. to "strong-buy".
Show more
Ratings data for TNXP provided by MarketBeat
Tonix Pharmaceuticals (TNXP) was downgraded by Wall Street Zen from "hold" to "sell".
Show more
Ratings data for TNXP provided by MarketBeat